Logos Capital
43 portfolio companies · 6 on the map · $3.6B raised · 5 cities
Portfolio map
6 Logos Capital portfolio companies on the map.
Portfolio companies

Ocular Therapeutix
Bedford
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Pharmaceutical Manufacturing$1.2BEst. 2006
Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Compass Pathways
London
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Mental Health Care$771.2MEst. 2016
Synthego
Menlo Park
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Biotechnology Research$459.7MEst. 2012
Mirador Therapeutics
San Diego
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Biotechnology Research$250MEst. 2024- A
Allakos
Redwood City
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Biotechnology ResearchPublic
More portfolio companies
35 more Logos Capital investments we track beyond the map — 43 tracked in total.
Parse BiosciencesSeattle · Series B
WillowMountain View · Series C
Vigil NeuroscienceCambridge · Series B
Biomea FusionRedwood City · Series A
Rapport TherapeuticsBoston · Series B
RayzeBioSan Diego · Series C
Design TherapeuticsSolana Beach · Series B
Dianthus TherapeuticsWaltham · Post-IPO Equity
ElektrofiBoston · Series C
Angitia BiopharmaceuticalsWestlake Village · Series D
Verve TherapeuticsBoston · Series B
Boundless BioLa Jolla · Series C
Enliven TherapeuticsBoulder · Post-IPO Equity
ProfoundBioSeattle · Series B
Repare TherapeuticsSaint Laurent · Series B
Centessa PharmaceuticalsCambridge · Series A
Aligos TherapeuticsSan Francisco · Series B
AffinivaxCambridge · Series C
AttralusSan Francisco · Series B
Vanqua BioChicago · Series B
YarrowNew York · Venture
ArvinasNew Haven · Post-IPO Equity
Simcha TherapeuticsNew Haven · Series B
VistaGenSan Francisco · Post-IPO Equity
ALX OncologySan Francisco · Series C
Pliant TherapeuticsSouth San Francisco · Series C
DTx PharmaSan Diego · Series B
Rain OncologyNewark · Series B
Black Diamond TherapeuticsCambridge · Series C
Akero TherapeuticsCambridge · Post-IPO Equity
Passage BioPhiladelphia · Series B
Alpine Immune SciencesSeattle · Post-IPO Equity
Ikena OncologyBoston · Series B
Delcath SystemsNew York · Post-IPO Equity
Viracta TherapeuticsCardiff By The Sea · Post-IPO Equity
Portfolio map
6 Logos Capital portfolio companies on the map.